The optimization of recombinant antibody production in Chinese Hamster Ovary (CHO) cells is a crucial aspect of biopharmaceutical development. To maximize production, various strategies are employed, including protein engineering of the host cells and optimization of media conditions. Furthermore, integration of advanced production systems can si